Arkolith/Insider Trading/KLRS/Form 4

Akkaraju Srinivas

Director, 10% OwnerKalaris Therapeutics, Inc. (KLRS) · full profile →Form 4 · filed May 22, 2026
Net Buying
Open-Market Buys
$1.2M
Open-Market Sells
$0
Net Open-Market Flow
$1.2M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Buy(P)244K$4.83$1.2M2.2M
May 20, 2026Other(J)67K—$010.7M
May 20, 2026Other(J)15K—$015K
May 20, 2026Other(J)4K—$019K

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000532) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML